📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: MS-Omics

1.1 - Company Overview

MS-Omics Logo

MS-Omics

Headquarter: Denmark
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of metabolomics and data analysis services for small to large studies, offering fee-for-service analyses to universities and companies in biotechnology, pharmacy, and food. Capabilities include microbiome metabolite measurement (with Clinical-Microbiomics for next-generation sequencing), clinical, cell and bacteria, nutritional, and animal metabolomics, leveraging advanced mass spectrometry.

Products and services

  • Clinical Metabolomics: Multi-matrix service analyzing saliva, faeces, caecum, urine, and blood to improve clinical research outcomes and support development of personalized medicine for healthcare studies
  • Metabolomics Analysis: Scalable, fee-for-service metabolomics for universities and companies in biotechnology, pharmacy, and food, supporting small to large studies through comprehensive analysis for academic and industrial research
  • Microbiome Analysis: NGS-integrated techniques measuring metabolites in cell tissue, faeces, blood, and urine, delivered via collaboration with Clinical-Microbiomics to enrich microbiome studies with next-generation sequencing data

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to MS-Omics

Caribou Biosciences Logo

Caribou Biosciences

HQ: United States Website
  • Description: Provider of CRISPR genome-editing technologies and allogeneic CAR-T cell therapies for oncology. Offers chRDNA to enhance precision and reduce off-target effects; off-the-shelf CAR-T therapies for hematologic malignancies and autoimmune diseases; and candidates CB-010 (anti-CD19 for B cell non-Hodgkin lymphoma), CB-011 (anti-BCMA for multiple myeloma), and CB-012 (anti-CLL-1 for acute myeloid leukemia).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Caribou Biosciences company profile →
Pierian Logo

Pierian

HQ: United States Website
  • Description: Provider of genomic SaaS solutions, a CAP and CLIA accredited laboratory, and a shared knowledgebase to enable physicians in the laboratory and clinic to diagnose and treat cancer and other complex diseases. Offerings include the Clinical Genomics Workspace, a knowledgebase with over 350,000 inferencing rules, professional services, IVD partnerships, EMR/LIS/EDW integration, and wet lab workflow guidance.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pierian company profile →
Codexis Logo

Codexis

HQ: United States Website
  • Description: Provider of enzyme discovery and RNA manufacturing solutions, offering the CodeEvolver platform to discover, develop, and enhance novel enzymes and proteins; ECO Synthesis technology for scaled enzymatic production of RNAi therapeutics; custom enzymes to improve small molecule pharmaceutical manufacturing; RNA ligase screening and optimization; and high-yield RNA manufacturing services.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Codexis company profile →
Enevolv Logo

Enevolv

HQ: United States Website
  • Description: Provider of engineered and licensed microorganisms (i.e., bacteria and yeast) that produce chemicals, enzymes, and small molecules, advancing cost-effective, sustainable bioengineering solutions to address growing demand in energy, food, and medicine.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Enevolv company profile →
ReadCoor Logo

ReadCoor

HQ: United States Website
  • Description: Provider of the first true spatial multi-omic platform (RC2) that simultaneously detects and reads sequences, serving a global audience of researchers, clinicians, pharma and diagnostics companies to expand understanding of human biology and facilitate the creation of new therapeutics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ReadCoor company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for MS-Omics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to MS-Omics

2.2 - Growth funds investing in similar companies to MS-Omics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for MS-Omics

4.2 - Public trading comparable groups for MS-Omics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to MS-Omics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About MS-Omics

What does MS-Omics do?

MS-Omics is a provider of metabolomics and data analysis services for small to large studies, offering fee-for-service analyses to universities and companies in biotechnology, pharmacy, and food. Capabilities include microbiome metabolite measurement (with Clinical-Microbiomics for next-generation sequencing), clinical, cell and bacteria, nutritional, and animal metabolomics, leveraging advanced mass spectrometry.

Who are MS-Omics's competitors?

MS-Omics's competitors and similar companies include Caribou Biosciences, Pierian, Codexis, Enevolv, and ReadCoor.

Where is MS-Omics headquartered?

MS-Omics is headquartered in Denmark.

How many employees does MS-Omics have?

MS-Omics has 1,000 employees 🔒.

When was MS-Omics founded?

MS-Omics was founded in 2010 🔒.

What sector and industry vertical is MS-Omics in?

MS-Omics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for MS-Omics

Who are the top strategic acquirers in MS-Omics's sector and industry

Top strategic M&A buyers and acquirers in MS-Omics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for MS-Omics?

Top strategic M&A buyers groups and sectors for MS-Omics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in MS-Omics's sector and industry vertical

Which are the top PE firms investing in MS-Omics's sector and industry vertical?

Top PE firms investing in MS-Omics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in MS-Omics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in MS-Omics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in MS-Omics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to MS-Omics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in MS-Omics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for MS-Omics?

The key public trading comparables and valuation benchmarks for MS-Omics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for MS-Omics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for MS-Omics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in MS-Omics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for MS-Omics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in MS-Omics's' sector and industry vertical?

Access recent funding rounds and capital raises in MS-Omics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for MS-Omics

Launch login modal Launch register modal